tiprankstipranks
Trending News
More News >
Karyopharm Therapeutics (KPTI)
NASDAQ:KPTI

Karyopharm Therapeutics (KPTI) Revenue

Compare
1,218 Followers

Karyopharm Therapeutics Revenue

Karyopharm Therapeutics had a revenue of 34.08M in the quarter ending Dec 31, 2025, with -22.63%. This bring the company's revenue in the last twelve months to 146.07M, Decreased 2.48%. In the fiscal year ending Dec 31, 2025, Karyopharm Therapeutics had annual revenue of 146.07M with 0.57% growth.
Revenue (ttm)
146.07M
Revenue Growth
-3.98%
P/S Ratio
0.96
Revenue/Employee
$523,538
Employees
279
Market Cap
$139.96M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
146.07M830.00K+0.57%
Dec 31, 2024
145.24M-796.00K-0.55%
Dec 31, 2023
146.03M-11.04M-7.03%
Dec 31, 2022
157.07M-52.74M-25.14%
Dec 31, 2021
209.82M101.73M+94.12%
Dec 31, 2020
108.08M67.19M+164.31%
Dec 31, 2019
40.89M10.56M+34.80%
Dec 31, 2018
30.34M28.73M+1,790.09%
Dec 31, 2017
1.60M